LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000104 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 16, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
14,461
Total Value
$1,857,560.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 12, 2026 | Exercise/Conversion | 3,000 | $51.56 | $154,680.00 | 10,442 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 12, 2026 | Exercise/Conversion | 1,000 | $51.56 | $51,560.00 | 11,442 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 12, 2026 | Sale | 3,000 | $255.01 | $765,033.90 | 8,442 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 12, 2026 | Sale | 3,461 | $256.08 | $886,286.30 | 4,981 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Jun 12, 2026 | Exercise/Conversion | 3,000 | $0.00 | $0.00 | 7,138 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Jun 12, 2026 | Exercise/Conversion | 1,000 | $0.00 | $0.00 | 6,138 | Direct | โ | View Details |